It was reported that a patient who was implanted on (b)(6) 2024 had a low-speed advisory on (b)(6) 2024, which was the date they were taken back to the operating room for urgent right ventricular assist device (rvad) removal.Log file review was requested, and it was confirmed that the low-speed advisory on (b)(6) 2024 was due to the set speed being briefly set below the low-speed limit.
|
Manufacturer's investigation conclusion: a direct correlation between the heartmate 3 left ventricular assist system (lvas), serial number (b)(6), and the reported right heart failure (rhf) could not be conclusively established through this evaluation.The controller event log file contained events from (b)(6) 2024.No notable events or alarms were captured, and the pump appeared to function as intended at the fixed speed.Multiple attempts were made to obtain additional information regarding the reported events; however, no further information was provided by the account.The patient remains ongoing on heartmate 3 lvas, serial number (b)(6).No further related events have been reported at this time.The relevant sections of the device history records for (b)(6) were reviewed and showed no deviations from manufacturing or quality assurance specifications.The heartmate 3 left ventricular assist system (lvas) instructions for use (ifu), rev.C, and the heartmate 3 patient handbook, rev.D, are currently available.Section 1 of the ifu, ¿introduction¿, lists adverse events, including right heart failure, that may be associated with the use of the heartmate 3 left ventricular assist system.Section 6 of the ifu (under "right heart failure") discusses the potential development of right heart failure following implant and outlines the associated treatment options, including inotropes and right ventricular assist device (rvad) placement.No further information was provided.The manufacturer is closing the file on this event.
|